Sectors
KOD
Kodiak Sciences Inc.
41.90
1 x 41.81
1 x 41.99
bid
ask
-
0.52
1.24%
01:40 PM
timesize
| Ytd | 49.84% | |
| 1y | 650.82% |
41.12
day range
42.85
5.00
52 week range
47.84
| Open | 41.78 | Prev Close | 42.42 | Low | 41.12 | High | 42.85 | Mkt Cap | 2.25B |
| Vol | 176.76K | Avg Vol | 720.39K | EPS | -4.17 | P/E | -10.17 | Forward P/E | -13.25 |
| Beta | 2.19 | Short Ratio | 11.72 | Inst. Own | 99.64% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 37.01 | 200-d Avg | 29.25 | 1yr Est | 62.67 |
| Income Statement | |||
| Operating Expenses | 59.78M | ||
| Research and Development Expense | 48.55M | ||
| Selling, General and Administrative Expense | 11.23M | ||
| Operating Income | -59.78M | ||
| Net Income | -58.16M | ||
| Net Income Common Stock | -58.16M | ||
| Net Income Common Stock (USD) | -58.16M | ||
| Consolidated Income | -58.16M | ||
| Earnings per Basic Share | -0.94 | ||
| Earnings per Basic Share (USD) | -0.94 | ||
| Earnings per Diluted Share | -0.94 | ||
| Earning Before Interest & Taxes (EBIT) | -58.16M | ||
| Earning Before Interest & Taxes (USD) | -58.16M | ||
| Weighted Average Shares | 61.86M | ||
| Weighted Average Shares Diluted | 61.86M | ||
| Balance Sheet | |||
| Cash and Equivalents | 175.71M | ||
| Cash and Equivalents (USD) | 175.71M | ||
| Current Assets | 175.26M | ||
| Property, Plant & Equipment Net | 115.89M | ||
| Total Assets | 306.01M | ||
| Debt Current | 11.66M | ||
| Total Debt | 155.99M | ||
| Current Liabilities | 49.57M | ||
| Debt Non-Current | 144.33M | ||
| Total Liabilities | 193.91M | ||
| Accumulated Retained Earnings (Deficit) | -1.62B | ||
| Shareholders Equity | 112.10M | ||
| Shareholders Equity (USD) | 112.10M | ||
| Assets Non-Current | 130.75M | ||
| Total Debt (USD) | 155.99M | ||
| Liabilities Non-Current | 144.33M | ||
| Trade and Non-Trade Payables | 11.34M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 6.34M | ||
| Net Cash Flow from Financing | 619.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -40.33M | ||
| Capital Expenditure | -942.00K | ||
| Issuance (Purchase) of Equity Shares | 922.00K | ||
| Net Cash Flow from Investing | -942.00K | ||
| Net Cash Flow from Operations | -40.01M | ||
| Share Based Compensation | 12.16M | ||